Loading briefing details...
News Abstract
By: PointLine Media Research & Editorial Team
Topic:Business,Health,Industry,Science & Environment
November 11, 2026
Creative Biolabs has detailed a framework for selecting RNA profiling methods to better study cellular heterogeneity. The company emphasizes that bulk gene expression analysis often obscures rare cell populations and transient states, necessitating more precise, targeted techniques.
The company provides three distinct methods to address different experimental requirements: single-cell RNA sequencing (scRNA-seq), single-nucleus RNA sequencing (snRNA-seq), and single-molecule fluorescence in situ hybridization (smFISH). Each approach serves a specific purpose based on sample integrity and the biological question at hand.
Choosing the correct method is essential for navigating the challenges of tissue dissociation and sample preservation. While scRNA-seq is effective for viable, dissociated cells, snRNA-seq offers an alternative for frozen or difficult-to-dissociate tissues, and smFISH allows for the precise visualization of transcript localization.
The shift toward single-cell resolution is transforming how researchers map tissue complexity. By moving beyond bulk sequencing, scientists can now identify specific cell states and rare populations that were previously masked, which is critical for advancements in cancer research, immunology, and developmental biology.
However, the diversity of biological samples—ranging from fresh biopsies to preserved archival tissue—means there is no universal approach. As the field matures, the focus is moving toward integrating multiple analytical workflows to ensure that data accuracy is maintained across different experimental constraints.